🇫🇷 Oncodesign Precision Medicine

ALOPM.PA

Healthcare · France · EUR · oncodesign.com

Fundamentals

Gross Margin

5.8%

Op. Margin

-20.2%

Net Margin

-2.9%

ROIC

10.5%

Rev Growth

26.1%

Valuation

Price

0.23 EUR

Day

-4.17%

52-Week Range

0.23 - 0.92

Market Cap

4M EUR

Fwd P/E

0.4x

EV/EBITDA

1.5x

Div Yield

Annual income statement #

Oncodesign Precision Medicine annual revenue, operating income and net income in EUR, 2020 to 2025. Revenue was 261,148 in 2025.

Year	Revenue (EUR)	Operating income	Net income	Net margin
2025	261,148	8.2m	5.5m
2024	207,040	-7.8m	-7.2m
2023	1.1m	-9.9m	-8.1m
2022	8.0m	-1.6m	-231,181	-2.9%
2021	3.8m	-3.7m	-2.9m	-76.9%
2020	4.4m	-6.2m	-153,826	-3.5%

Financial Data #

Segment Breakdown #

Price & Multiples #

Peers #

Events #

Date	Type	Details	Price	Amount